IL2 and capillary leak syndrome: The incidence of CLS due to IL-2 (18 studies) was 34.7% by overall estimation and 43.9% by meta-analysis, and the corresponding figures for BMT were 21.1% and 21.7%, respectively CLS was also reported in cases receiving other agents.